Centre René Gauducheau

Nantes 44805

0 studies enrolling now · 2 studies all time

What they study most

Gastrointestinal Stromal Tumors, Neoplasms

Studies at this site

• Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) — Stopped early
• Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors — Completed